Finasteride and Dutasteride for Prostate Enlargement
Finasteride and dutasteride for prostate enlargement are not quick urine-flow tablets. They are slow-acting medicines that shrink an enlarged prostate over months. They may help men with a clearly enlarged prostate, weak urine flow and risk of future urine blockage. They can also reduce the chance of sudden urinary retention or prostate surgery in selected patients. But they can affect sexual function and lower PSA blood test values, so they should not be started casually without proper urology evaluation.
What are finasteride and dutasteride?
Finasteride and dutasteride are medicines used in selected men with benign prostatic hyperplasia, also called BPH or prostate enlargement.
They belong to a group called 5-alpha reductase inhibitors, or 5-ARIs.
The prostate is a gland below the urinary bladder. With age, it can enlarge and press on the urine passage. This can cause weak urine flow, straining, frequent urination, waking up at night and incomplete bladder emptying.
These medicines are different from alpha blockers such as tamsulosin, silodosin or alfuzosin. Alpha blockers relax the prostate and bladder neck quickly. Finasteride and dutasteride work slowly by reducing the hormone effect that keeps the prostate enlarged.
Finasteride and dutasteride for prostate enlargement: how do they work?
The prostate grows partly under the influence of a hormone called dihydrotestosterone, or DHT. DHT is made from testosterone by an enzyme called 5-alpha reductase.
Finasteride and dutasteride block this enzyme. This lowers DHT activity inside the prostate. Over time, the prostate may shrink. When the pressure on the urine passage reduces, urine flow may improve.
This is why patients often call them prostate shrinking tablets. However, the benefit is gradual and usually needs regular use for several months.
Who benefits most from finasteride or dutasteride?
These medicines are most useful when urinary symptoms are due to a truly enlarged prostate.
- Enlarged prostate on ultrasound or clinical examination
- Moderate to severe urinary symptoms due to BPH
- Weak urine flow with a large prostate
- Higher risk of sudden urine blockage
- Recurrent symptoms despite initial medicines
- Prostate-related bleeding in selected cases
- Need for long-term medical treatment instead of immediate surgery
Guidelines generally support 5-ARI treatment when prostate enlargement is present and there is risk of progression. In practical OPD care, prostate size, PSA, urine flow, residual urine and symptom severity all matter.
Who may not benefit much?
Finasteride and dutasteride may not help much if the main problem is not prostate enlargement.
- Small prostate size
- Burning urination due to infection
- Overactive bladder
- Uncontrolled diabetes causing frequent urination
- Urethral stricture
- Excess evening fluid intake causing night urination
- Sleep disturbance causing frequent waking
- Need for quick symptom relief
This is why evaluation matters. Not every older man with urinary symptoms has BPH as the main cause.
Finasteride vs dutasteride: practical comparison
| Point | Finasteride | Dutasteride |
|---|---|---|
| Medicine group | 5-alpha reductase inhibitor | 5-alpha reductase inhibitor |
| Main role | Slowly shrinks enlarged prostate | Slowly shrinks enlarged prostate |
| Symptom relief | Slow, usually over months | Slow, usually over months |
| Best suited for | Enlarged prostate with progression risk | Enlarged prostate with progression risk |
| PSA effect | Can lower PSA | Can lower PSA |
| Sexual side effects | Possible | Possible |
| Used with alpha blockers? | Sometimes | Sometimes |
| Better choice? | Depends on evaluation | Depends on evaluation |
For most patients, the key question is not which tablet is stronger, but whether a prostate-shrinking medicine is needed at all.
How long do these medicines take to work?
Finasteride and dutasteride work slowly. Meaningful clinical benefit is usually judged after at least several months, often six months or longer. Guideline data show that 5-alpha reductase inhibitors can reduce prostate volume by roughly 18-28% over 6-12 months in appropriately selected men.
This slow action is important. If a man has severe symptoms, a urologist may combine a 5-ARI with an alpha blocker. The alpha blocker gives earlier symptom relief. The 5-ARI works slowly to reduce prostate size and future risk.
What symptoms can improve?
- Weak urine stream
- Straining to pass urine
- Incomplete bladder emptying
- Frequent urination due to obstruction
- Night urination related to BPH
- Recurrent risk of urinary retention in suitable patients
But if frequency is mainly due to diabetes, infection, overactive bladder or sleep problems, these tablets alone may not solve the problem.
Can finasteride or dutasteride prevent catheterisation or surgery?
In selected men, yes. Their biggest benefit is not just symptom relief. They can reduce the long-term risk of acute urinary retention, catheterisation and future BPH-related prostate surgery.
However, they cannot avoid surgery in every patient. Surgery may still be needed if there is repeated urine retention, bladder stones, kidney swelling due to blockage, recurrent infection, blood in urine due to prostate enlargement, very poor urine flow or failure of medicines.
Possible side effects
Most men tolerate these medicines, but side effects can happen.
- Reduced sexual desire
- Erection difficulty
- Reduced semen volume
- Ejaculation changes
- Breast tenderness
- Breast swelling
- Mood changes in some men
- Skin rash or allergic reaction, rarely
Do not feel embarrassed to discuss these issues. Sexual side effects are medical issues, not a personal weakness. A urologist can decide whether to continue, stop, change medicines or look for other causes such as diabetes, low testosterone, stress, vascular disease or other medicines.
Important PSA warning
This is one of the most important points.
Finasteride and dutasteride can lower PSA. PSA is a blood test used during prostate evaluation, including assessment for prostate cancer risk.
After several months on these medicines, PSA may fall substantially. Guideline data show that 5-alpha reductase inhibitors typically lower PSA by about 50% after 6-12 months. PSA must therefore be interpreted with the medicine history, treatment duration and PSA trend in mind rather than using the untreated reference value blindly.
- PSA should often be checked before starting treatment, depending on age and clinical situation
- Later PSA values must be interpreted by a doctor who knows you are taking these medicines
- A normal PSA while on these medicines may not mean the same thing as a normal PSA without them
- Rising PSA while on finasteride or dutasteride should not be ignored
- Always tell your doctor if you are taking these medicines before PSA interpretation
Do not start these tablets from a pharmacy without a prostate evaluation and PSA plan.
Can these medicines hide prostate cancer?
They do not simply hide cancer, but they can make PSA interpretation more complicated. Because PSA often falls after starting finasteride or dutasteride, cancer detection can be delayed if PSA is interpreted casually.
Baseline PSA and follow-up interpretation are important, especially in older men or men with risk factors.
When should you see a urologist before starting these medicines?
See a urologist if you have:
- Weak urine flow
- Straining to pass urine
- Frequent urination
- Waking up multiple times at night
- Feeling of incomplete emptying
- Urine dribbling after passing urine
- Burning urination
- Blood in urine
- Recurrent urinary infection
- High PSA
- Catheter placed for urine blockage
- Kidney swelling on ultrasound
- Previous prostate or urethral surgery
A urologist can check whether your symptoms are due to prostate enlargement, infection, bladder overactivity, diabetes, urethral stricture or another cause.
Emergency warning signs
Seek urgent medical care if you have:
- Sudden inability to pass urine
- Severe lower abdominal pain with inability to urinate
- Fever, chills and burning urination
- Blood clots in urine
- Severe weakness, vomiting or confusion with urinary infection
- Very low urine output
- Back pain with fever and urinary symptoms
| Important: | These symptoms may need urgent catheterisation, antibiotics, imaging or hospital care. Do not wait for prostate medicines to work in an emergency. |
|---|
What tests may be needed?
Your urologist may advise:
- Urine routine and microscopy
- Urine culture if infection is suspected
- Serum creatinine to check kidney function
- PSA blood test when appropriate
- Ultrasound KUB with prostate size
- Post-void residual urine measurement
- Uroflowmetry to check urine flow
- Digital rectal examination when needed
- Cystoscopy in selected cases
Not every patient needs every test. The plan depends on age, symptoms, prostate size, PSA, urine findings and red flags.
What happens after starting treatment?
After starting finasteride or dutasteride, review is important. Your urologist may check symptom improvement, urine flow, side effects, PSA trend, residual urine, need for combination treatment and whether surgery should be considered.
Do not stop the medicine suddenly just because symptoms improve. If stopped, the prostate may gradually enlarge again and symptoms may return.
If you are considering finasteride or dutasteride for prostate enlargement, a urology evaluation helps confirm whether your prostate is actually enlarged and whether these medicines are suitable for you.
What should you bring for consultation?
- Ultrasound KUB/prostate report
- PSA report
- Urine routine report
- Urine culture report, if done
- Serum creatinine report
- Uroflowmetry report, if done
- List of current medicines
- Diabetes and BP reports
- Catheter or discharge summary, if any
- Previous prostate surgery records
- Details of sexual side effects or fertility concerns
FAQs
Are finasteride and dutasteride quick urine-flow medicines?
No. They are slow-acting prostate-shrinking medicines. They usually take several months to show meaningful benefit.
Do these medicines actually shrink the prostate?
Yes, in suitable men with enlarged prostate, they can shrink prostate tissue over time by lowering DHT activity.
Can I take finasteride or dutasteride without ultrasound?
It is better to confirm prostate size before starting. These medicines are most useful when the prostate is enlarged.
Can I take these medicines without PSA testing?
Do not self-start. PSA may need to be checked before starting, especially in older men. These medicines can lower PSA and make later interpretation more complex.
Do finasteride and dutasteride affect sexual function?
They can. Some men notice reduced sexual desire, erection difficulty, ejaculation changes or reduced semen volume. Discuss this openly with your urologist.
Which is better: finasteride or dutasteride?
Both can help in suitable patients. The better choice depends on prostate size, symptoms, PSA, side effects, other medicines and urologist assessment.
Can these medicines prevent prostate surgery?
They can reduce the risk of urinary retention and future surgery in selected men with enlarged prostate. But surgery may still be needed if symptoms are severe or complications develop.
Can I stop the medicine once I feel better?
Do not stop without medical advice. If stopped, the prostate may enlarge again over time and symptoms may return.
Are these the same tablets used for hair loss?
Finasteride is also used in different treatment plans for hair loss, but prostate treatment is different. Do not use hair-loss medicines as prostate treatment without urology evaluation.
Related reading
- Enlarged Prostate: Symptoms, Causes and Treatment
- BPH: Benign Prostatic Hyperplasia Explained
- Prostate Medicines Explained
- Alpha Blockers for Prostate Enlargement
- Side Effects of Prostate Medicines
- Can Prostate Medicines Affect Sexual Function?
- Prostate Size on Ultrasound: Does Size Matter?
- Weak Urine Flow in Men: Causes and Treatment
- Sudden Inability to Pass Urine
- Catheter for Prostate Problem
- TURP Surgery for Prostate Enlargement
- Enlarged Prostate / BPH Treatment
- Urologist in Latur
References
- European Association of Urology. EAU Guidelines on Management of Non-neurogenic Male LUTS – Disease Management https://uroweb.org/guidelines/management-of-non-neurogenic-male-luts/chapter/disease-management
- American Urological Association. Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline https://www.auanet.org/guidelines-and-quality/guidelines/benign-prostatic-hyperplasia-bph-guideline
- NICE Clinical Knowledge Summaries. LUTS in men: 5-alpha reductase inhibitors and voiding symptoms https://cks.nice.org.uk/topics/luts-in-men/
- Urology Care Foundation. Benign Prostatic Hyperplasia – Prescription Drugs )/treatment/prescription-drugs https://www.urologyhealth.org/urology-a-z/b/benign-prostatic-hyperplasia-(bph
- Kim EH, Brockman JA, Andriole GL. The use of 5-alpha reductase inhibitors in the treatment of benign prostatic hyperplasia. Asian Journal of Urology https://pmc.ncbi.nlm.nih.gov/articles/PMC5780290/